Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 14 04:00PM ET
3.72
Dollar change
+0.07
Percentage change
1.92
%
IndexRUT P/E- EPS (ttm)-0.93 Insider Own77.10% Shs Outstand670.87M Perf Week6.59%
Market Cap2.59B Forward P/E- EPS next Y-0.74 Insider Trans0.00% Shs Float159.51M Perf Month3.91%
Income-597.65M PEG- EPS next Q-0.17 Inst Own8.87% Short Float33.02% Perf Quarter-41.87%
Sales1.31M P/S1977.93 EPS this Y25.22% Inst Trans-4.09% Short Ratio18.93 Perf Half Y-29.01%
Book/sh-1.01 P/B- EPS next Y13.95% ROA-162.50% Short Interest52.68M Perf Year190.62%
Cash/sh0.31 P/C11.89 EPS next 5Y-1.70% ROE- 52W Range1.25 - 10.53 Perf YTD-25.90%
Dividend Est.- P/FCF- EPS past 5Y1.17% ROI-203.07% 52W High-64.67% Beta0.90
Dividend TTM- Quick Ratio3.88 Sales past 5Y195.19% Gross Margin-1284.56% 52W Low197.60% ATR (14)0.23
Dividend Ex-Date- Current Ratio3.91 EPS Y/Y TTM17.43% Oper. Margin-27459.33% RSI (14)52.28 Volatility7.47% 6.34%
Employees628 Debt/Eq- Sales Y/Y TTM120.95% Profit Margin-45691.67% Recom2.00 Target Price6.38
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q37.85% Payout- Rel Volume0.67 Prev Close3.65
Sales Surprise-93.04% EPS Surprise-25.00% Sales Q/Q2453.66% EarningsAug 05 Avg Volume2.78M Price3.72
SMA205.06% SMA50-1.69% SMA200-27.97% Trades Volume1,860,624 Change1.92%
Date Action Analyst Rating Change Price Target Change
May-12-23Downgrade Piper Sandler Overweight → Neutral $10 → $4
Aug-03-22Initiated Jefferies Buy $8
Sep-09-24 08:30AM
Aug-12-24 08:46AM
Aug-06-24 09:00AM
Jul-01-24 03:26AM
Jun-26-24 09:41AM
09:00AM Loading…
Jun-20-24 09:00AM
06:15AM
Jun-07-24 09:13AM
May-17-24 09:00AM
May-10-24 09:53AM
May-09-24 06:01AM
May-07-24 08:00AM
May-06-24 06:00AM
May-02-24 04:04PM
May-01-24 10:05AM
08:00AM Loading…
Apr-30-24 08:00AM
Apr-25-24 12:03AM
Apr-23-24 04:55PM
Apr-22-24 09:56PM
Apr-19-24 11:02AM
Mar-19-24 09:53PM
Mar-14-24 08:45AM
Mar-06-24 09:00AM
Mar-05-24 09:00AM
Feb-21-24 09:00AM
Feb-05-24 09:00AM
Jan-02-24 07:10AM
06:00AM
Nov-16-23 09:00AM
Nov-07-23 09:00AM
09:00AM Loading…
Oct-26-23 09:00AM
Oct-23-23 09:00AM
Oct-09-23 08:45AM
Sep-11-23 06:00AM
Aug-03-23 09:00AM
Jul-20-23 08:32PM
Jul-10-23 09:30AM
May-22-23 09:00AM
Apr-25-23 09:00AM
Apr-24-23 11:28PM
Feb-16-23 09:00AM
Feb-15-23 09:00AM
Jan-19-23 09:00AM
Dec-12-22 08:30AM
Nov-17-22 09:00AM
Nov-10-22 05:21PM
Oct-27-22 08:00AM
Jul-28-22 04:18PM
Jul-26-22 04:17PM
Jun-30-22 10:00AM
Jun-14-22 11:25AM
Jun-06-22 09:00AM
May-23-22 08:32AM
May-16-22 07:29AM
Apr-28-22 09:00AM
Apr-25-22 09:00AM
Apr-01-22 04:15PM
Mar-02-22 09:00AM
Feb-21-22 09:32AM
Feb-18-22 12:13PM
Feb-15-22 09:00AM
09:00AM
Feb-14-22 05:17PM
Jan-31-22 07:16PM
Jan-21-22 09:38PM
Jan-19-22 07:34AM
Jan-18-22 06:00PM
Jan-13-22 09:00AM
Jan-12-22 08:30AM
08:30AM
Jan-04-22 09:00AM
Jan-03-22 08:00AM
Dec-20-21 09:00AM
Dec-07-21 06:38AM
Nov-18-21 09:00AM
Nov-08-21 05:14PM
08:00AM
Nov-04-21 09:00AM
Oct-19-21 09:00AM
Oct-13-21 09:00AM
Oct-04-21 08:30AM
Sep-13-21 08:30AM
Sep-07-21 08:30AM
Sep-01-21 09:00AM
Aug-16-21 09:00AM
Jul-27-21 09:00AM
Jul-14-21 09:00AM
Jun-28-21 09:00AM
Jun-23-21 04:05PM
Jun-15-21 07:00AM
Jun-10-21 09:00AM
04:35AM
May-25-21 09:00AM
May-24-21 09:00AM
May-20-21 09:00AM
May-17-21 09:00AM
May-04-21 09:00AM
Apr-29-21 09:00AM
Apr-22-21 09:00AM
Apr-08-21 09:00AM
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Adcock RichardCEO & PresidentFeb 05 '24Option Exercise0.0083,3340286,303Feb 06 09:14 PM
Simon Barry J.DirectorJan 31 '24Option Exercise0.0057,20003,145,855Feb 02 07:38 PM
Sachs David C.Chief Financial OfficerJan 31 '24Option Exercise0.0070,7450212,673Feb 02 07:33 PM
LAUER REGAN JChief Accounting OfficerJan 31 '24Option Exercise0.0032,8720107,804Feb 02 07:32 PM
Sachs David C.Chief Financial OfficerDec 31 '23Option Exercise0.0030,3970152,439Jan 03 09:41 PM
Adcock RichardCEO & PresidentDec 31 '23Option Exercise0.0034,4830220,065Jan 03 09:40 PM
LAUER REGAN JChief Accounting OfficerDec 15 '23Option Exercise0.0021,030074,932Dec 19 04:41 PM